Honestly, I don't know whether to cheer or cry over this news. Amgen halted all human trials of GDNF in September 2004.... Amgen sat on their patent for GDNF for over 5 years. Here's hoping that MedGenesis and Biovail will move the research forward quickly and successfully through clinical trials, and wil realize that patients can be valuable research partners if given the chance.
All i can add to Paula's posting is "AMEN"